Trends in Treatment for Prostate Cancer in China: Preliminary Patterns of Care Study in a Single Institution

被引:19
作者
Zhao, Feng [1 ]
Shen, Jiayan [1 ]
Yuan, Zuguo [1 ]
Yu, Xiaokai [1 ]
Jiang, Peng [2 ]
Zhong, Baishu [3 ]
Xiang, Jianjian [4 ]
Ren, Guoping [5 ]
Xie, Liping [2 ]
Yan, Senxiang [1 ]
机构
[1] Zhejiang Univ, Coll Med, Dept Radiat Oncol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Med, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, Coll Med, Dept Radiol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[4] Zhejiang Univ, Coll Med, Dept Ultrasound, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[5] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China
来源
JOURNAL OF CANCER | 2018年 / 9卷 / 10期
关键词
prostate cancer (PCa); Patterns of Care Study (PCS); treatment modalities; radical prostatectomy (RP); radiotherapy (RT); ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADICAL PROSTATECTOMY; TUMOR CHARACTERISTICS; OUTCOMES; MEN; SURGERY; OLD;
D O I
10.7150/jca.25113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: A Patterns of Care Study (PCS) was performed in the largest regional medical center in Zhejiang Province, China. The hospital information system (HIS) was used to evaluate patient characteristics and changes in initial treatment patterns for prostate cancer and to determine recent predominant trends in treatment plans for prostate cancer (PCa) in China. Methods: Men who were newly diagnosed with localized or locally advanced PCa for 2010-2011 and 2016-2017 were identified in the HIS database. Patient characteristics and temporal trends in initial management were assessed, and differences between groups were evaluated for significance using Chi-square and Mann-Whitney U tests. Results: In total, 1792 patients met the study criteria, including 505 and 1287 patients in the 2010-2011 and 2016-2017 samples, respectively. The average age of patients diagnosed in the 2010-2011 PCS survey was 70 years, decreasing to 68 years when the 2016-2017 patients were included (P<0.001). In the 2010-2011 sample, 50.69% of the patients had an initial prostate-specific antigen (PSA) level >= 20 ng/ml. In contrast, the initial PSA level was 4-19.99 ng/ml for 66.67% of the patients in the 2016-2017 sample (P<0.001). Based on National Comprehensive Cancer Network (NCCN) criteria, the percentages of patients in low- and intermediate-risk groups increased from 33.06% to 54.78%; conversely, the percentages in high-risk, very high-risk, and regional (N1) groups decreased to a certain extent (P<0.001). According to European Association of Urology (EAU) criteria, the percentages of patients in low- and intermediate-risk groups increased from 32.07% to 53.69%, yet the percentage in the high-risk group decreased (P<0.001). The use of radical prostatectomy (RP) and radiation therapy (RT) increased from 48.32% to 76.46% and 5.35% to 16.94%, particularly in high-risk and low-risk groups, respectively, whereas the rates of hormone therapy (HT) and active surveillance and observation (AS&O) decreased from 32.28% to 4.27% and from 16.04% to 2.33%, respectively (P<0.001). A similar pattern was observed when patients were stratified by EAU risk group. Conclusions: The results of this real-world study in the largest regional medical center in Zhejiang Province, China, indicate that the predominant characteristics of PCa patients and trends in initial management are changing rapidly. We found the following: (a) a trend toward a decreased age among newly diagnosed patients; (b) a trend toward lower initial PSA levels; (c) a downward trend in risk group classification; (d) a significant increase in the likelihood of receiving RP, particularly in the high-risk group; (e) an increase in the rate of RP, mostly due to use of the Da Vinci robotic system; (f) a significant increase in the likelihood of receiving RT, especially in the low-risk group; and (g) a decrease in HT and AS&O.
引用
收藏
页码:1797 / 1803
页数:7
相关论文
共 50 条
  • [31] A Preliminary Study of PSMA Fluorescent Probe for Targeted Fluorescence Imaging of Prostate Cancer
    Zhou, Haoxi
    Liu, Yachao
    Zhang, Xiaojun
    Chen, Kuang
    Li, Yuan
    Xu, Xiaodan
    Xu, Baixuan
    MOLECULES, 2022, 27 (09):
  • [32] Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?
    O'Callaghan, Michael
    Papa, Nathan
    Pase, Marie
    Frydenberg, Mark
    Mark, Stephen
    Moretti, Kim
    Maqsood, Saad
    Smith, David
    Walker, Tony
    White, Craig
    Millar, Jeremy
    BJU INTERNATIONAL, 2021, 128 : 6 - 8
  • [33] Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China
    Ruan, Xiao-Hao
    Chun, Tsun Tsun Stacia
    Huang, Da
    Wong, Hoi-Lung
    Ho, Brian Sze-Ho
    Tsang, Chiu-Fung
    Lai, Terence Chun-Ting
    Ng, Ada Tsui-Lin
    Na, Rong
    Tsu, James Hok-Leung
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 345 - 349
  • [34] Trends Related to the Treatment of Superior Labral Tears at a Single Institution
    Davis, Daniel E.
    Zmistowski, Benjamin
    Ball, Christopher
    Patel, Manan S.
    Kane, Liam T.
    Lazarus, Mark
    ARCHIVES OF BONE AND JOINT SURGERY-ABJS, 2021, 9 (01): : 58 - 63
  • [35] Prostate cancer treatment-China?s perspective
    Liu, Jiazhou
    Dong, Liang
    Zhu, Yinjie
    Dong, Baijun
    Sha, Jianjun
    Zhu, Helen He
    Pan, Jiahua
    Xue, Wei
    CANCER LETTERS, 2022, 550
  • [36] A multidisciplinary group for prostate cancer management: A single institution experience
    Colasante, Antonella
    Auguri, Antonietta
    Basilico, Raffaella
    Cotroneo, Antonio Raffaele
    Di Sciascio, Maria B.
    Gaspari, Giuseppe
    Genovesi, Domenico
    Giampietro, Jamara
    Iantorno, Romina
    Marchetti, Antonio
    Natoli, Clara
    Nuzzo, Antonello
    Ottaviani, Floriana
    Pompa, Paolo
    Castellan, Pietro
    Tenaglia, Raffaele
    Vinciguerra, Annamaria
    ONCOLOGY LETTERS, 2018, 15 (02) : 1823 - 1828
  • [37] Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures
    Lee, Daniel J.
    Barocas, Daniel A.
    Zhao, Zhiguo
    Huang, Li-Ching
    Koyama, Tatsuki
    Resnick, Matthew J.
    Conwill, Ralph
    McCollum, Dan
    Cooperberg, Matthew R.
    Goodman, Michael
    Greenfield, Sheldon
    Hamilton, Ann S.
    Hashibe, Mia
    Kaplan, Sherrie H.
    Paddock, Lisa E.
    Stroup, Antoinette M.
    Wu, Xiao-Cheng
    Penson, David F.
    Hoffman, Karen E.
    PRACTICAL RADIATION ONCOLOGY, 2018, 8 (05) : 307 - 316
  • [38] Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study
    Kjellstadli, Camilla
    Forster, Rachel B.
    Myklebust, Tor A.
    Bjorge, Tone
    Bonaa, Kaare H.
    Helle, Svein I.
    Kvale, Rune
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP group
    Minana, B.
    Rodriguez-Antolin, A.
    Gomez-Veiga, F.
    Hernandez, C.
    Suarez, J. F.
    Fernandez-Gomez, J. M.
    Unda, M.
    Burgos, J.
    Alcaraz, A.
    Rodriguez, P.
    Moreno, C.
    Pedrosa, E.
    Cozar, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (04): : 209 - 216
  • [40] Nationwide treatment patterns and survival of older patients with prostate cancer
    Vernooij, Robin W. M.
    van Oort, Inge
    de Reijke, Theo M.
    Aben, Katja K. H.
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (02) : 252 - 258